Colgate-Palmolive Company (NYSE:CL) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Colgate-Palmolive Company (NYSE:CL) have been given a consensus recommendation of “Moderate Buy” by the fifteen research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $89.8667.

Several analysts recently weighed in on CL shares. The Goldman Sachs Group decreased their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. Citigroup cut their price target on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a report on Monday. Raymond James Financial lowered their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Barclays cut their target price on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research note on Tuesday. Finally, Piper Sandler started coverage on shares of Colgate-Palmolive in a research report on Friday, October 3rd. They issued a “neutral” rating and a $84.00 price target on the stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $78.76 on Friday. The firm has a market capitalization of $63.65 billion, a PE ratio of 22.12, a PEG ratio of 4.44 and a beta of 0.35. Colgate-Palmolive has a 1 year low of $74.54 and a 1 year high of $100.18. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The firm’s fifty day simple moving average is $79.73 and its 200 day simple moving average is $85.77.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.91 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Institutional Trading of Colgate-Palmolive

Several institutional investors have recently bought and sold shares of the stock. Westside Investment Management Inc. lifted its holdings in shares of Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the period. Cornerstone Planning Group LLC increased its position in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after purchasing an additional 287 shares in the last quarter. Saudi Central Bank bought a new position in Colgate-Palmolive during the 1st quarter valued at about $29,000. Copia Wealth Management acquired a new position in Colgate-Palmolive in the third quarter valued at about $29,000. Finally, Vermillion & White Wealth Management Group LLC grew its stake in Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.